Vysioneer is a startup based in the United States, 1 tracked investor.
Vysioneer is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Vysioneer develops AI-powered tools to analyze tumor heterogeneity in oncology trials, enabling earlier and more precise assessment of treatment efficacy using lesion-level biomarker data.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.